![]() |
Pharmacy CE ACPE Accredited Continuing Education for Pharmacists and Pharmacy Technicians |
Primary Prevention of Cardiovascular Diseases Webcast – 1.5 CE

Activity Overview
The use of low-dose aspirin especially in elderly patients as a primary prevention strategy needs to be balanced with potential risk of adverse events, such as bleeding. In the past, low dose of aspirin was recommended to prevent stroke and myocardial infarction. However, recent evidence indicates that aspirin use in patients with low to moderate risk of cardiovascular diseases (CVD) is not associated with reduction in CVD. Rather, it presents with an increased risk of bleeding. The use of statin in patients at risk of CVD has evolved with recent evidence recommending the use of pooled cohort equation to calculated 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk when determining if a patient can benefit from statin use as primary prevention strategy.
Evidence from latest clinical trials will be presented to assist participating audience in determining when the use of low dose aspirin and statin is recommended. Healthcare professionals will be able to make recommendation to de-prescribe inappropriate use of low-dose aspirin where no added benefit is shown. The use of statin with its correct dosing will be reviewed allowing healthcare professionals to calculate 10-year ASCVD risk to guide decision making.
Pharmacist Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:
- Explain the benefit of early detection and prevention of cardiovascular diseases
- Discuss approaches for screening and risk estimation of CVD
- Examine the current evidence on the use of statin and aspirin for primary prevention of CVD
- Evaluate patient cases to stratify risk of developing CVD
- Design evidence-based treatment plans for prevention of CVD
Pharmacy Technician Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:
- Describe the benefit of early detection and prevention of cardiovascular diseases
- Familiarize with different approaches to screen and estimate risk for CVD
- Explain the role of pharmacotherapeutic options for primary prevention of CVD
- Discuss the current evidence-based recommendations on the use of statin and aspirin for primary prevention of CVD
Nurse Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:
- Describe the benefit of early detection and prevention of cardiovascular diseases
- Familiarize with different approaches to screen and estimate risk for CVD
- Explain the role of pharmacotherapeutic options for primary prevention of CVD
- Discuss the current evidence-based recommendations on the use of statin and aspirin for primary prevention of CVD
Accreditation Statement
AchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AchieveCE is also an accredited provider by the Florida Board of Nursing (Provider #50-20641) and the California Board of Registered Nursing (CEP17265), and is an approved provider through reciprocity for the states of Arkansas, District of Columbia, Georgia, Kentucky, New Mexico, South Carolina, and West Virginia. This course is approved by CE Broker, with CE Broker No. 20-868605.
Faculty Information
Shreya Patel, PharmD, BCPSÂ is an Associate Professor of Pharmacy Practice of the School of Pharmacy and Health Sciences at Fairleigh Dickinson University. She has no actual or potential conflicts of interest to disclose
Financial Support Disclosure
This activity was developed by AchieveCE free of any commercial support.
Content Complexity
  Level 2. Basic Application of Skills and Concepts
Delivery Type
Home Study Webcast
Credits
1.0 Contact Hour
Category
Disease State Management/Drug Therapy
Target Audience
Pharmacist
Pharmacy Technician
Nurse
Activity Type
Knowledge-based
Universal Activity Number
Pharmacist:Â
0657-0000-22-041-H01-P
Pharmacy Technician:
0657-0000-22-041-H01-T
Activity Release Date
April 11, 2022
Activity Expiration Date
April 11, 2025
Cost
Handout Download Link(s)
Already a Member?
Requirements for Credit
Participants must score a passing grade of 70% or higher on the activity post-test and complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CPE Monitor and/or CE Broker if your license information is entered properly in your profile.
CE Broker Reporting
If you are licensed under a board supported by CE Broker, feel free to log into your CE Broker account to view your reported courses or to contact their support staff.

Hardware Requirements
Windows 8.1, Windows 10
Mac OS X 10.1 or higher
iOS 10+, Android 4.3+
Software Requirements
Google Chrome, Microsoft Edge, Mozilla Firefox
Adobe Acrobat Reader
Network Requirements
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
Get Unlimited CE!
Get unlimited CE for one low annual fee.
Save time and money by becoming a member!
Need more Pharmacy CEs?
Check out other live webinars and home study activities to study at your own time!